SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alfacell (ACEL)
ACEL 11.54-0.9%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Greg Kevorkian who wrote (1408)6/23/1998 10:56:00 AM
From: Tom DuBois  Read Replies (1) of 1533
 
Greg...I see your points and don't dispute them. My question, however, remains unanswered. Why is ACEL any different from other biotechs with good science?? We all blame the PR firm (with good reason) but discovery is a two way process. Surely there are dozens of analysts whose ONLY job is to sniff out these "blockbuster" microcaps to be first on the "next AMGEN train". ACEL should not be able to stay undiscovered even if they wanted to be. My fear (I know, Leighton, I know nothing about financing either) is that analysts are looking and are not comfortable with what they see.

What do we really expect to happen in two months that will tell who is right and who is wrong??

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext